Unique ID issued by UMIN | UMIN000028015 |
---|---|
Receipt number | R000032076 |
Scientific Title | The feasibility study for pancreatic cancer screening by plasma biomarker using apoA2-isoforms. |
Date of disclosure of the study information | 2017/07/04 |
Last modified on | 2025/01/29 11:14:11 |
The feasibility study for pancreatic cancer screening by plasma biomarker using apoA2-isoforms.
Feasibility study of apoA2-i
The feasibility study for pancreatic cancer screening by plasma biomarker using apoA2-isoforms.
Feasibility study of apoA2-i
Japan |
Pancreatic cancer
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Adult |
Malignancy
NO
The aim of this study is to get the proof of concept of the efficient screening method pancreatic cancer screening. We will calculate the of samples that need in next the randomized trial from the result of this study.
Efficacy
Exploratory
Explanatory
Not applicable
Ditection rate of the pancreatic cancer
Detection rate and positive predictive value of the pancreatic disorders including pancreatic cancer. 2. Survival time and mortality.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
1
Prevention
Other |
The first screening of pancreatic cancer by plasma apoA2-i. The second screening of pancreatic cancer by enhanced CT.
50 | years-old | <= |
Not applicable |
Male and Female
1. The subjects undergo the specific examination, job area examination, and multiphasic health screening in the specific screening institutes.
2. The subjects are more than 50 years old.
3. The subjects were not diagnosed before enrolled for thus study, with autoimmune pancreatitis, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, mucinous cystic neoplasm, pancreatic neuroendocrine tumor and Solid-pseudopapillary neoplasm.
4. The subjects are agreeing to participate in this study with a documentation.
1. The subjects underwent the pancreatectomy.
2. The subjects have undergone the treatmet for maligant disorders other than pancreatic cancer.
3. The subjects have the serious disorders, and 5-years survival cannot expect.
4. The subjects with the reasons which the medical institutions considered as inadequacy.
20000
1st name | kazufumi |
Middle name | |
Last name | Honda |
NIPPONMEDICALSCHOOL
biodynamics
113-8602
1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan
03-3822-2131
k-honda@nms.ac.jp
1st name | ayumi |
Middle name | |
Last name | kashiro |
NIPPONMEDICALSCHOOL
biodynamics
113-8602
1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan
03-3822-2131
a-kashiro@nms.ac.jp
NIPPONMEDICALSCHOOL
Japan Agency for Medical Research and Development
Government offices of other countries
Central Ethics Committee of Japan Medical University (JMU)
1-1-5 Sendagi, Bunkyo-ku, Tokyo
03-3822-2131
chuorinri.group@nms.ac.jp
NO
鹿児島県民総合保健センター(鹿児島)、鹿児島大学(鹿児島)、鹿児島市立病院(鹿児島)、出水市総合医療センター(鹿児島)、ホテルオークラ神戸クリニック(兵庫)、神戸大学医学部附属病院(兵庫)、北海道対がん協会がん検診センター(北海道)、北海道大学病院(北海道)
2017 | Year | 07 | Month | 04 | Day |
Unpublished
15000
No longer recruiting
2017 | Year | 06 | Month | 21 | Day |
2017 | Year | 06 | Month | 21 | Day |
2017 | Year | 07 | Month | 04 | Day |
2027 | Year | 03 | Month | 31 | Day |
2017 | Year | 06 | Month | 30 | Day |
2025 | Year | 01 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032076
Research Plan | |
---|---|
Registered date | File name |
2024/01/12 | 革新第7版計画書修正 AK20230110.pdf |
Research case data specifications | |
---|---|
Registered date | File name |
2024/01/12 | 新規 Microsoft Excel ワークシート.xlsx |
Research case data | |
---|---|
Registered date | File name |
2024/01/12 | 新規 Microsoft Excel ワークシート.xlsx |
Value
https://center6.umin.ac.jp/ice/32076